Respiratory Viruses Coinfections During the COVID-19 Pandemic in Southern Brazil
Authors:
- Dayane Azevedo PadilhaDPDayane Azevedo Padilha
- Fernando Hartmann BarazzettiFBFernando Hartmann Barazzetti
- Marcos André SchörnerMSMarcos André Schörner
- Henrique Borges da Silva GrisardHenrique Borges da Silva Grisard
- Vilmar Benetti FilhoVFVilmar Benetti Filho
- Eric Kazuo KawagoeEKEric Kazuo Kawagoe
- Doris Sobral Marques SouzaDSDoris Sobral Marques Souza
- Maria Luiza BazzoMBMaria Luiza Bazzo
- Glauber WagnerGWGlauber Wagner
- Gislaine FongaroGislaine Fongaro
Open Access
Abstract
Since December 2019, the COVID-19 pandemic caused by SARS-CoV-2 has reached approximately 769 million people, leading to more than 7 million deaths worldwide. Faced with the possibility of other respiratory pathogens co-infecting patients and modifying their clinical response to SARS-CoV-2, some researchers have explored this line of investigation. The relationship between these co-infections remains unclear, underscoring the need to deepen our understanding of interactions among pathogens and between pathogens and the host. Thus, the present study employed RT-qPCR to assess the presence of Human Adenovirus (HAdV), Influenza A (Flu A), Influenza B (Flu B), Human Metapneumovirus (HMPV), Respiratory Syncytial Virus (RSV), Human Rhinovirus (HRV), and Parainfluenza Virus (PIV). Nasopharyngeal samples (187) from adult patients exhibiting respiratory symptoms were collected between February 2021 and November 2022 at the University Hospital Polydoro Ernani de São Thiago in Florianópolis, SC, Brazil. The present findings revealed that 25.16% of samples tested positive for non-SARS-CoV-2 respiratory viruses (29.8%—HRV; 5.3%—PIV; 4.3%—RSV; and 1.1%—HMPV). In the 74.84% of SARS-CoV-2-positive patients, co-infection was observed in 9.7% of patients, with 7.5% being HRV, 1.1% HAdV, and 1.1% Influenza A. Since co-infections can potentially alter patient prognoses and impact local epidemiological dynamics, this study highlights the significance of ongoing monitoring and epidemiological assessment through genomic surveillance of other clinically relevant respiratory pathogens.Keywords
Funding Information
- Fundação de Amparo à Pesquisa e Inovação de Santa Catarina (COV2020051000065, COV2020051000099)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (COV2020051000065, COV2020051000099)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (COV2020051000065, COV2020051000099)
- Universidade Federal de Santa Catarina (COV2020051000065, COV2020051000099)
This publication has 13 references indexed in Scilit:
- The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variantJournal of Clinical Virology, 2022
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysisThe Lancet, 2022
- SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenovirusesThe Lancet, 2022
- Respiratory Pathogen Coinfections in SARS-CoV-2-Positive Patients in Southeastern Wisconsin: A Retrospective AnalysisMicrobiology Spectrum, 2021
- The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in GermanyEmerging Microbes & Infections, 2021
- Bacterial co‐infections with SARS‐CoV‐2IUBMB Life, 2020
- Rates of Co-infection Between SARS-CoV-2 and Other Respiratory PathogensJAMA, 2020
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe Lancet, 2020
- Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-AnalysisThe Journal of Infectious Diseases, 2019
- Viral infection in community-acquired pneumonia: a systematic review and meta-analysisEuropean Respiratory Review, 2016